Correlation Between Chemours and Consilium Acquisition

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Chemours and Consilium Acquisition at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Chemours and Consilium Acquisition into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Chemours Co and Consilium Acquisition I, you can compare the effects of market volatilities on Chemours and Consilium Acquisition and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Chemours with a short position of Consilium Acquisition. Check out your portfolio center. Please also check ongoing floating volatility patterns of Chemours and Consilium Acquisition.

Diversification Opportunities for Chemours and Consilium Acquisition

0.32
  Correlation Coefficient

Weak diversification

The 3 months correlation between Chemours and Consilium is 0.32. Overlapping area represents the amount of risk that can be diversified away by holding Chemours Co and Consilium Acquisition I in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Consilium Acquisition and Chemours is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Chemours Co are associated (or correlated) with Consilium Acquisition. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Consilium Acquisition has no effect on the direction of Chemours i.e., Chemours and Consilium Acquisition go up and down completely randomly.

Pair Corralation between Chemours and Consilium Acquisition

Allowing for the 90-day total investment horizon Chemours Co is expected to under-perform the Consilium Acquisition. In addition to that, Chemours is 3.04 times more volatile than Consilium Acquisition I. It trades about -0.01 of its total potential returns per unit of risk. Consilium Acquisition I is currently generating about 0.03 per unit of volatility. If you would invest  1,020  in Consilium Acquisition I on September 14, 2024 and sell it today you would earn a total of  149.00  from holding Consilium Acquisition I or generate 14.61% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Chemours Co  vs.  Consilium Acquisition I

 Performance 
       Timeline  
Chemours 

Risk-Adjusted Performance

4 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Chemours Co are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of rather unfluctuating fundamental indicators, Chemours may actually be approaching a critical reversion point that can send shares even higher in January 2025.
Consilium Acquisition 

Risk-Adjusted Performance

12 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Consilium Acquisition I are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively stable primary indicators, Consilium Acquisition is not utilizing all of its potentials. The recent stock price uproar, may contribute to short-horizon losses for the private investors.

Chemours and Consilium Acquisition Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Chemours and Consilium Acquisition

The main advantage of trading using opposite Chemours and Consilium Acquisition positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Chemours position performs unexpectedly, Consilium Acquisition can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Consilium Acquisition will offset losses from the drop in Consilium Acquisition's long position.
The idea behind Chemours Co and Consilium Acquisition I pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.

Other Complementary Tools

Bonds Directory
Find actively traded corporate debentures issued by US companies
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios